SynthesisDiabetes, obesity & metabolism2019

GLP-1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis including the REWIND and PIONEER 6 trials.

Dario Giugliano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.